86.06 +0.21 (0.24%)
IDXX
| Trade IDXX now with |
|
Stock Details
Last Trade:86.06 Change:+0.21 (0.24%) Prev Close:85.85 Open: 85.84 Days Range:84.82 – 86.39 52 Week Range: 63.83 - 87.69 Volume:112678 P/E: 30.96EPS:2.78
View AllRecent Alerts 02/09/12
Recent Alert on 01/27/12 at 7:03am
Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook
Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook
Idexx Labs (NASDAQ: IDXX) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $307.2 million versus the consensus estimate of $303.97 million. Idexx Labs sees FY2012 EPS of $3.04-$3.10,... Read More
Recent Alert on 01/27/12 at 7:03am
Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook
Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook
Recent Alert on 01/26/12 at 5:58pm
Trading Radar for 01/27: Ford (F), Chevron (CVX), D.R. Horton (DHI), Honeywell (HON) Reports
Trading Radar for 01/27: Ford (F), Chevron (CVX), D.R. Horton (DHI), Honeywell (HON) Reports
Recent Alert on 01/06/12 at 8:55am
Canaccord Genuity Starts Abaxis Inc. (ABAX) at Hold; Vet and Medical Markets Show Signs of Stabilizing
Canaccord Genuity Starts Abaxis Inc. (ABAX) at Hold; Vet and Medical Markets Show Signs of Stabilizing
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 01/27/12 at 11:48am
IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript
IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Blog Posts on 01/09/12 at 9:18pm
IDEXX Laboratories CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
IDEXX Laboratories CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)